TY - JOUR
T1 - Role of a Pediatric Cardiologist in the COVID-19 Pandemic
AU - Niaz, Talha
AU - Hope, Kyle
AU - Fremed, Michael
AU - Misra, Nilanjana
AU - Altman, Carrie
AU - Glickstein, Julie
AU - Sanchez-de-Toledo, Joan
AU - Fraisse, Alain
AU - Miller, Jacob
AU - Snyder, Christopher
AU - Johnson, Jonathan N.
AU - Chowdhury, Devyani
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/1
Y1 - 2021/1
N2 - Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early reports have shown that younger age groups experience less severe disease than older adults, our understanding of this phenomenon is in continuous evolution. Recently, a severe multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. Children with MIS-C may demonstrate signs and symptoms of Kawasaki disease, but also have some distinct differences. These children have more frequent and severe gastrointestinal symptoms and are more likely to present with a shock-like presentation. Moreover, they often present with cardiovascular involvement including myocardial dysfunction, valvulitis, and coronary artery dilation or aneurysms. Here, we present a review of the literature and summary of our current understanding of cardiovascular involvement in children with COVID-19 or MIS-C and identifying the role of a pediatric cardiologist in caring for these patients.
AB - Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early reports have shown that younger age groups experience less severe disease than older adults, our understanding of this phenomenon is in continuous evolution. Recently, a severe multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. Children with MIS-C may demonstrate signs and symptoms of Kawasaki disease, but also have some distinct differences. These children have more frequent and severe gastrointestinal symptoms and are more likely to present with a shock-like presentation. Moreover, they often present with cardiovascular involvement including myocardial dysfunction, valvulitis, and coronary artery dilation or aneurysms. Here, we present a review of the literature and summary of our current understanding of cardiovascular involvement in children with COVID-19 or MIS-C and identifying the role of a pediatric cardiologist in caring for these patients.
KW - COVID-19
KW - Cardiovascular
KW - MIS-C
KW - Pediatric
UR - http://www.scopus.com/inward/record.url?scp=85092015919&partnerID=8YFLogxK
U2 - 10.1007/s00246-020-02476-y
DO - 10.1007/s00246-020-02476-y
M3 - Review article
C2 - 33015722
AN - SCOPUS:85092015919
SN - 0172-0643
VL - 42
SP - 19
EP - 35
JO - Pediatric Cardiology
JF - Pediatric Cardiology
IS - 1
ER -